GlassScriptPhysician profile
Lorelei C Capocyan
NPI 1679756936
$2,169.01
in general payments reported to CMS, 2019-2025
19 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $198 · 2021: $166 · 2022: $141 · 2023: $1,185 · 2024: $109 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Food and Beverage | $470.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $1,011.81 | 2023 | Tirosint, Tirosint, Licart |
| Exeltis, USA INC. | $234.66 | 2019-2025 | Slynd |
| Abbvie INC. | $173.40 | 2021-2023 | Lo Loestrin Fe |
| Amgen INC. | $122.08 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $117.23 | 2019 | |
| Hologic Sales and Service, LLC | $75.62 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $75.00 | 2022-2024 | Veozah |
| Mayne Pharma Commercial LLC | $73.25 | 2023-2025 | |
| Mylan Pharmaceuticals INC. | $57.04 | 2020-2022 | |
| Abbott Laboratories | $43.25 | 2025 | Freestyle Libre 3 |
| Sk Life Science, INC. | $31.66 | 2024 | |
| Medtronic, INC. | $29.81 | 2025 | Truclear |
| Shield Therapeutics INC | $22.55 | 2023 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $19.84 | 2019 | |
| Evofem Biosciences, INC. | $18.58 | 2025 | Solosec, Phexx, Phexxi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $17.70 | 2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $17.02 | 2023 | Xarelto |
| Therapeuticsmd, INC. | $14.96 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $13.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorelei Capocyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.